Research and Development

Showing 15 posts of 9594 posts found.

AstraZeneca plaque

Cambridge collaboration to boost precision medicine research

July 29, 2015 Research and Development Brabaham Institute, Cambridge, R&D, collaboration

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …
Scales of justice

Judge rules pharma has ‘ethical’ transparency obligation – reaction

July 29, 2015 Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …
Gavel

Judge backs HRA in transparency legal case

July 28, 2015 Research and Development EU Clinical Trial Regulation, Richmond Pharmacology, alltrials, clinical trial regulation, clinical trials, health research authority, sense about science, transparency

A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …
Regeneron building

Sanofi and Regeneron in immuno-oncology push

July 28, 2015 Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1

Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …
Antibiotic resistance

Rising to meet the infectious disease challenge

July 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Antibiotics, R&D, antibiotic resistance, infectious disease

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …
EMA

EMA in push for more paediatric drug trials

July 24, 2015 Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics

The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
alzheimers_brain

Lilly, Biogen and Roche debut Alzheimer’s disease drug results

July 22, 2015 Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …
Opdivo

BMS halts Opdivo kidney cancer trial early

July 22, 2015 Research and Development BMS, Bristol-Myers Squibb, European Commission, Kidney cancer, opdivo, renal cell carcinoma

Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015 Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
rtorbett

New ABPI executive director appointed

July 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett

The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …
Malthouse_Freeman

Parliamentary launch for UK life sciences group

July 21, 2015 Manufacturing and Production, Research and Development All Party Parliamentary Group on Life Sciences, Kit Malthouse, george freeman, government, lobbying, parliament

A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …

It’s time the industry spoke out about legal challenge to clinical trial transparency

July 16, 2015 Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …

Industry awaits outcome of transparency legal challenge

July 16, 2015 Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …
The Gateway to Local Adoption Series

Latest content